Create 3D cell models with the RASTRUM™ Platform

Create 3D cell models with the RASTRUM™ Platform

The easy solution for creating 3D cell models

RASTRUM™ Matrices

Ready-to-use, consistent, xeno-free matrix

Supports a diverse range of cell and tissue types

Optically clear for high quality in situ imaging

RASTRUM™ Instrument

Intuitive user experience, no coding required

Design your experiments from anywhere

Integrated dual HEPA filtration

RASTRUM™ Models

Compatible with standard well plates

Integrates seamlessly with your downstream analysis

Complex spatial cell and matrix arrangement

The RASTRUM™ platform has revolutionized our ability to create highly organized and reproducible 3D breast and ovarian cancer models in a stable and tuneable tumour microenvironment that is not possible in 2D. Combined with standard imaging platforms, this technology will certainly advance our ability to better understand, model and treat these diseases.

Dr John R. Hawse

Dr John R. Hawse

Associate Professor of Biochemistry and Molecular Biology, Mayo Clinic

The RASTRUM™ platform has enabled us to recreate humanized beating cardiac 3D organoids from induced pluripotent stem cells (iPSC). The organoids can be printed at the iPSC stage and differentiated in the plugs, allowing us to study cells across their development. The scale enabled by the RASTRUM™ platform means we can test for the interaction of genetics on drug response, identifying patient-specific cardiotoxicity events.

Professor Joseph Powell

Professor Joseph Powell

Director of Cellular Science, Genomic-led Drug Discovery Program Lead at the Garvan Institute of Medical Research, Director of the UNSW Cellular Genomics Futures Institute

The RASTRUM™ platform has enabled us to recreate humanised endocrine 3D primary breast cancer models, in a physiologically-relevant and defined tumour microenvironment that cannot be achieved using traditional approaches.

Marie_Mcilroy_RCSI

Dr Marie McIlroy

Lecturer, Department of Surgery, Royal College of Surgeons in Ireland

The RASTRUM™ bioprinter has allowed us to successfully maintain and expand primary samples of children's cancer in high throughput that have otherwise proved difficult to grow in vitro by recapitulating a physiologically relevant 3D tumour extracellular environment.

Professor Maria Kavallaris

Professor Maria Kavallaris

Head of the Translational Cancer Nanomedicine Theme, Children's Cancer Institute

The RASTRUM™ platform has allowed us to efficiently and reproducibly generate 3D brain organoids from induced pluripotent stem cells for our research on neurodegenerative disease

Dr Nicolas Dzamko

Dr Nicolas Dzamko

Senior Research Fellow, University of Sydney

Using the RASTRUM™ platform, we have developed fully defined patient-derived liver cancer models for high throughput drug development in environments more accurately recreating the unique liver microenvironment than traditional organoid culture methods.

Dr Ben Dwyer

Dr Ben Dwyer

Senior Research Fellow, Curtin University

Stand out from the rest with RASTRUM™

The award-winning advanced 3D cell model platform

    Good Design Award
    Fast Company World Changing Ideas 2020
    AM EurekaPrizes
    Most Innovative Companies
RASTRUM Instrument
Speak to a specialist

Latest updates

New advancements for generating more accurate 2D and 3D models of the human brain

Phenotypic 3D cell models: Benefits and how to get started

3D cell culture models for cancer drug discovery

Tunable 3D cell models recapitulating the tumour microenvironment for in vitro immuno-oncology assays

Neural Marker Expression in Adipose-Derived Stem Cells Grown in PEG-Based 3D Matrix Is Enhanced in the Presence of B27 and CultureOne Supplements

The epithelial adherens junction component PLEKHA7 regulates ECM remodeling and cell behavior through miRNA-mediated regulation of MMP1 and LOX

Macrophage variance: investigating how macrophage origin influences responses to soluble and physical cues with immortalized vs. primary cells in 2D and 3D culture

EGFR and PI3K Signalling Pathways as Promising Targets on CTCs from Patients with Metastatic Gastric Adenocarcinoma

Processing and Paraffin-Embedding of RASTRUM™ Removable Model

Cryosectioning of RASTRUM™ Removable Models

Want to stay in the loop with the latest?